BioMed Israel Conference 2026

NeuroKaire at BioMed Israel

NeuroKaire was proud to participate in BioMed Israel, one of the leading life sciences and health technology conferences in the region, bringing together innovators, researchers, healthcare leaders, investors, and industry partners shaping the future of medicine.

As part of the "Beyond NeuroPharma and NeuroTech" session, Dr. Talia Cohen Solal, CEO and Co-founder of NeuroKaire, presented NeuroKaire’s vision for transforming mental healthcare through precision psychiatry. Her presentation explored how NeuroKaire is moving beyond understanding disease mechanisms toward predicting treatment response using patient-derived neurons and artificial intelligence.

The session highlighted how BrightKaire™ leverages patient-specific biology to generate actionable insights that can help clinicians make more informed antidepressant treatment decisions. By combining stem cell technology, neuroscience, and AI-driven analytics, NeuroKaire is working to reduce the trial-and-error process in depression care and improve outcomes for patients living with mental health conditions.

Highlights:

• Presentation by Dr. Talia Cohen Solal, CEO & Co-founder of NeuroKaire
• Featured speaker in the Beyond NeuroPharma and NeuroTech session
• Discussion of NeuroKaire’s patient-derived neuron platform and AI-driven approach
• Insights into the future of predictive and personalized psychiatry
• Engagement with healthcare innovators, researchers, investors, and industry leaders

BioMed Israel provided a valuable platform to share NeuroKaire’s progress in precision psychiatry and connect with organizations dedicated to advancing the future of healthcare through innovation and scientific discovery.

Missed Us at NAMICon?

If you weren’t able to attend, we’d still love to connect! Learn more about how NeuroKaire’s solutions can benefit your practice and improve patient outcomes.

Contact Us or Schedule a Meeting